.jpg)
Doctor
Huashan hospital Fudan university
Dr. Zongze Li, Ph.D., M.D., neurosurgeon and attending physician ,Department of neurosurgery, Huashan Hospital, Fudan University.
Dr. Li completed his Master's degree at Beijing Tiantan Hospital, Capital Medical University. Dr. Li's primary research focus centers on longitudinal studies of brainstem cavernous malformations, and Dr. Li has been a key participant in a clinical study investigating drug treatments for this condition. To date, Dr. Li' has authored 199 SCI papers in esteemed journals such as Neurology, Stroke, International Journal of Neurosurgery, and Journal of Neurosurgery. In 2023, he presented at the Annual Meeting of the Congress of Neurological Surgeons (CNS) in the United States.
EDUCATION AND TRAINING
2008 - 2013 University of South China M.D.
2013 - 2019 Beijing Tiantan Hospital, Capital Medical University Residency (Neurosurgery)
2019 - 2021 Peking University International Hospital, Assistant Professor
2021 - present Fudan University Ph.D.
July, 2023 Chinese National Center for Neurological Diseases Young Neurosurgeon exchange program
RESEARCH ACTIVITIES SUMMARY
Clinical research focused on the hemorrhage risk and neurological outcome assessment tools for brainstem cerebral cavernous malformation (BSCMs). Conducting a retrospective, multicenter cohort study to identify the natural history and neurological outcomes of treatment in BSCMs (REALM study, Clinical Study of Brainstem Cavernous Malformations Prognosis, ClinicalTrials.gov registered: ChiCTR2300070907). Design and coordinating a prospective clinical trial to explore the drug therapy for cavernous malformations. (CALM study, Hemorrhagic Brainstem Cavernous Malformations Treatment with Sirolimus: a Pilot Study, ClinicalTrials.gov registered:NCT06091332). Work experience of independent statistical analysis with R software and SPSS.
AREAS OF INTEREST
Management strategy and risk stratification of cerebrovascular diseases. Pathogenesis and therapies for cerebrovascular diseases. Novel targeted drug therapy for cranial cavernous malformations.
ACADEMIC AND PUBLIC SERVICE
2020.10 - Present Peking University Neurosurgery Youth Committee Committee Member
2023.9 - Present Journal of Neurorestoratology Editorial Board
2019.8 - 2020.7 Chinese Xiangya Medical Journal Editorial Board
2023.9 - Present Chinese Neurosurgical Journal Reviewer
2023.9 - Present Frontiers in Neurology Reviewer